Both in Blank Checks
Oaktree Acquisition Corp. III Life Sciences vs Karman Line Acquisition
| Metric | OACC | XTER |
|---|---|---|
| Price | $10.72 | $9.77 |
| Market cap | $263.5M | $266.9M |
| Today | 0.00% | 0.00% |
| 1 month | −0.4% | −0.2% |
| 6 months | +1.0% | — |
| Year to date | +1.3% | — |
| 1 year | — | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | — |
| Dividend yield | — | — |
| Volatility (60d) | 7.2% | — |
| Short % of float | 0.0% | 0.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).